CTKB β€” CYTEK BIOSCIENCES INC

Ownership history in Savant Capital, LLC  Β·  2 quarters on record

This page tracks every 13F SEC filing in which Savant Capital, LLC reported a position in CYTEK BIOSCIENCES INC (CTKB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)    CTKB price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 2 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 29,703 +5,570 +23.1% 0.00% $103K $3.47
2025 Q2 INITIATED 24,133 β€” β€” 0.00% $82K $3.40

🏒 Other funds also holding CTKB

As of 2025 Q4 β€” sorted by position size

Topline Capital Management, LLC 3.4% HHLR ADVISORS, LTD. 3Y 7Y 1.08% BROWN CAPITAL MANAGEMENT LLC 3Y 7Y 0.86% Numerai GP LLC 3Y 0.11% ROYCE & ASSOCIATES LP 3Y 7Y 0.09% Dynamic Technology Lab Private Ltd 3Y 7Y 0.05% PDT Partners, LLC 3Y 7Y 0.03% Boston Partners 3Y 7Y 0.03% AXQ CAPITAL, LP 3Y 0.02% MILLENNIUM MANAGEMENT LLC 3Y 7Y 0.01%
← Back to Savant Capital, LLC Holdings